{"id":"W4213328782","doi":"10.1200/jco.2022.40.6_suppl.tps211","title":"PSMAfore: A phase 3 study to compare <sup>177</sup>Lu-PSMA-617 treatment with a change in androgen receptor pathway inhibitor in taxane-naïve patients with metastatic castration-resistant prostate cancer.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Enzalutamide; Prostate cancer; Taxane; Glutamate carboxypeptidase II; Androgen receptor; Internal medicine; Androgen deprivation therapy; Urology; Oncology; Androgen; Cancer research; Cancer; Hormone; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001396763,0.0016271,0.002162255,0.0005835292,0.0005461081,0.001415413,0.001313866,0.00186432,0.008560956],"category_scores_gemma":[0.0009899791,0.0006872179,0.002184338,0.0005356531,0.001285334,0.001422532,0.0004610603,0.004045765,0.001632316],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001429922,"about_ca_system_score_gemma":0.003130918,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002304824,"about_ca_topic_score_gemma":0.006259503,"domain_scores_codex":[0.9995759,0.0001629219,0.00002110671,0.00008905056,0.00004475779,0.0001062164],"domain_scores_gemma":[0.9989988,0.000121561,0.0001777577,0.00007874487,0.0000558982,0.0005672081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.848412,0.0631786,0.003329891,0.000686718,0.001297658,0.0001729915,0.0002394436,0.001811946,0.02133676,0.0003095233,0.002910909,0.05631355],"study_design_scores_gemma":[0.6986967,0.2931107,0.004446854,0.00002406391,0.0002526088,0.0001548383,0.00005180816,0.0004631981,0.001216334,0.0002232931,0.001337103,0.00002258208],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.987366,0.001551313,0.0005759613,0.000643499,0.0002380656,0.005399141,0.001670817,0.0001762775,0.002378892],"genre_scores_gemma":[0.9825278,0.001532722,0.002098581,0.001848844,0.00026904,0.004908084,0.003520906,0.00007000405,0.003224055],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008560956,"threshold_uncertainty_score":0.02863926,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1630714976411654,"score_gpt":0.4755667656597602,"score_spread":0.3124952680185949,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}